Characterization of Conformation-Sensitive Antibodies to ADAMTS13, the von Willebrand Cleavage Protease

• Zuben E. Sauna ,

  * E-mail: Zuben.sauna@fda.hhs.gov (ZES); Chava.kimchi-sarfaty@fda.hhs.gov (CKS)

  Affiliation Laboratory of Hemostasis, Division of Hematology, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland, United States of America

  ⨯
• Chinyere Okunji,

  Affiliation Laboratory of Hemostasis, Division of Hematology, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland, United States of America

  ⨯
• Ryan C. Hunt,

  Affiliation Laboratory of Hemostasis, Division of Hematology, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland, United States of America

  ⨯
• Tanvi Gupta,

  Affiliation Laboratory of Hemostasis, Division of Hematology, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland, United States of America

  ⨯
• Courtni E. Allen,

  Affiliation Laboratory of Hemostasis, Division of Hematology, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland, United States of America

  ⨯
• Elizabeth Plum,

  Affiliation Laboratory of Hemostasis, Division of Hematology, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland, United States of America

  ⨯
• Adam Blaisdell,

  Affiliation Laboratory of Hemostasis, Division of Hematology, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland, United States of America

  ⨯
• Vahan Grigoryan,

  Affiliation National Center for Biotechnology Information, National Library of Medicine, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Geetha S,

  Affiliation Laboratory of Hemostasis, Division of Hematology, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland, United States of America

  ⨯
• Robert Fathke,

  Affiliation Laboratory of Hemostasis, Division of Hematology, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland, United States of America

  ⨯
• Kenji Soejima,

  Affiliation First Research Department, the Chemo-Sero-Therapeutic Research Institute, Kumamoto, Japan

  ⨯
• Chava Kimchi-Sarfaty

  * E-mail: Zuben.sauna@fda.hhs.gov (ZES); Chava.kimchi-sarfaty@fda.hhs.gov (CKS)

  Affiliation Laboratory of Hemostasis, Division of Hematology, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland, United States of America

  ⨯